Sanofi (NASDAQ: SNY) Win EU Approval for Dupixent in Chronic Lung Disease
On Wednesday, Sanofi (NASDAQ: SNY) and partner Regeneron (NASDAQ: REGN) won European Union approval for wider use of their Dupixent […]
Sanofi (NASDAQ: SNY) Win EU Approval for Dupixent in Chronic Lung Disease Read More »
